India's Vape Ban: Total Failure and Public Health Crisis

Apr.15.2022
A survey in India shows overwhelming demand for safer nicotine alternatives and calls for the government to lift the vape ban.

This is the most significant independent investigation we have seen since India banned smoking in 2019. It shows an overwhelming demand for the government to lift the ban and regulate access to safer nicotine products," said Nancy Loucas, Executive Coordinator of the Coalition of Asia Pacific Tobacco Harm Reduction Advocates (CAPHRA).

 

She made her comments after the release of the "Smoke-Free Product User Survey," which was conducted by a research organization specializing in global public opinion research.

 

A recent survey found that a majority of people believe in using safer alternatives, with approximately 86% of respondents stating that electronic cigarettes and heated tobacco products are better substitutes for traditional cigarettes. Furthermore, 87% of the individuals believe that these products should be offered to adult smokers. Nevertheless, due to the enforcement of smoking bans, most former e-cigarette users are now forced to either resume smoking or turn to illegal means to purchase these products.

 

This clearly won't work. The Indian government must urgently reconsider its smoking ban. Indians are seeking alternatives to smoking, but they are forced to return to smoking or enter the unregulated black market of electronic cigarette products. For the populous people of this continent, this is a terrible public health crisis," said Loucas.

 

Hong Kong is moving in the same direction of development.

 

Similarly, a group of medical and scientific professionals from the Asia Pacific Advocates for Tobacco Harm Reduction Alliance (CAPHRA) have written a letter to local authorities explaining why Hong Kong's gradual move towards a complete ban on alternative nicotine products, such as e-cigarettes and heated tobacco products, could have unintended consequences.

 

In a letter addressed to Hong Kong Chief Executive Carrie Lam, a group of experts cautioned against recent concerns over a potential ban on media coverage. The group commended Hong Kong's goal to reduce smoking rates from the current 10.2% to 7.8% by 2025. "We believe that by appropriately regulating heated tobacco products, and supplementing Hong Kong’s existing strong tobacco control policies with harm reduction approaches, a significant reduction in smoking rates and improvements in public health outcomes can be achieved," they wrote.

 

They continue to reference peer-reviewed studies in the global scientific community and emphasize the growing consensus among the international scientific community that electronic nicotine delivery systems (ENDS), also known as vaping devices, are safer than traditional cigarettes and serve as a means to reduce harm caused by tobacco use. They mention Japan's significant success in reducing smoking rates through regulation of heated tobacco products.

 

Other countries and regions should take note.

 

In addition, a recent article in the South China Morning Post pointed out that, given Australia's lack of success in reducing smoking rates with its e-cigarette ban, Hong Kong should carefully reconsider implementing its own ban.

 

During the period from 2013 to 2016, smoking rates in Australia increased by over 21,000, reaching 2.4 million. "For the first time ever, smoking rates in Australia did not statistically decrease, while the number of smokers has actually increased," said renowned public health expert Colin Mendelsohn as early as 2017.

 

A public health expert advocating for the use of electronic cigarettes as a harm-reducing tool has pointed out that punitive and coercive measures taken by the country are clearly not effective. This argument is supported by data from the United Kingdom, which has adopted a different approach from Australia and has achieved historically low smoking rates.

 

Source: Vapingpost

 

India's ban on vaping has been deemed a complete failure.

 


Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

U.S. Customs Plan to Require Foreign Export Declarations Could Deal ‘Devastating’ Blow to China’s Vape Exports, Logistics gl Expert Says
U.S. Customs Plan to Require Foreign Export Declarations Could Deal ‘Devastating’ Blow to China’s Vape Exports, Logistics gl Expert Says
A U.S. Customs and Border Protection proposal to collect foreign export declarations and other overseas customs documents could expose discrepancies in the value, classification and description of China-made vape shipments entering the United States. A veteran Chinese logistics professional told 2Firsts that the measure, if implemented, could undermine the all-inclusive shipping model used by some unauthorized vape exporters and push parts of the trade toward costlier underground channels. The risk extends beyond higher duties: accurately declared products may also be more readily identified as unauthorized e-cigarettes subject to FDA enforcement.
Special Report
Sep.07
FDA Appoints Former Tobacco Enforcement Deputy Jessica Zeller as Director as Agency Weighs PMTA Framework Changes
FDA Appoints Former Tobacco Enforcement Deputy Jessica Zeller as Director as Agency Weighs PMTA Framework Changes
The U.S. Food and Drug Administration (FDA) has named Jessica Zeller director of the Center for Tobacco Products' (CTP) Office of Compliance and Enforcement (OCE), effective November 1, 2026. Zeller, the office's inaugural deputy director, returns from medical device manufacturer Edwards Lifesciences with more than 20 years of regulatory and legal experience. The appointment follows CTP leadership changes and adjustments to tobacco regulation. Bret Koplow became permanent CTP director in September; the FDA revised enforcement priorities for unauthorized e-cigarettes and nicotine pouches in May and announced faster PMTA review procedures. On September 28, the agency said it would evaluate changes to the existing PMTA regulatory framework, including potential rulemaking to replace it.
FDA
Oct.20 by 2Firsts Perspectives
Bret Koplow Takes Permanent Charge of FDA Tobacco Center After Pushing Faster PMTA Reviews, as HHS Emphasizes Innovation and Access to Lower-Risk Alternatives
Bret Koplow Takes Permanent Charge of FDA Tobacco Center After Pushing Faster PMTA Reviews, as HHS Emphasizes Innovation and Access to Lower-Risk Alternatives
The U.S. Department of Health and Human Services has named Bret Koplow permanent director of the FDA’s Center for Tobacco Products, ending his period as acting chief. Koplow has spent years working on tobacco regulation, law and policy inside the FDA and, while serving as acting director, pushed for faster PMTA reviews and nicotine pouch review pilots. HHS also said CTP will prioritize innovation and access to less harmful alternatives for adult smokers while continuing efforts to protect youth.
Sep.09
EU Tobacco Tax Reform Targets November Push as Sweden Holds Nicotine-Pouch Minimum at €20 per Kilogram
EU Tobacco Tax Reform Targets November Push as Sweden Holds Nicotine-Pouch Minimum at €20 per Kilogram
The Irish presidency of the Council of the European Union is using bilateral talks to push the bloc’s Tobacco Taxation Directive toward a political agreement in November. According to Law360, citing an EU official, Sweden is unwilling to accept a minimum excise threshold above €20 per kilogram for nicotine pouches. Council negotiations have already lowered the European Commission’s original proposal, but a May 2026 presidency compromise still set the minimum at 10% of the tax-inclusive retail price or €30 per kilogram in 2028-29, with higher levels later.
Market
Sep.17 by 2Firsts Perspectives
Cochrane 2026 Update Adds Nine Trials, Keeps High-Certainty Finding That Nicotine E-Cigarettes Improve Quit Rates Over NRT
Cochrane 2026 Update Adds Nine Trials, Keeps High-Certainty Finding That Nicotine E-Cigarettes Improve Quit Rates Over NRT
Cochrane’s 2026 update of its living review on electronic cigarettes for smoking cessation included 80 randomized controlled trials involving 29,861 adult smokers, with nine trials added in this update. The review retained its high-certainty conclusion that nicotine e-cigarettes increase smoking cessation rates compared with nicotine replacement therapy. In absolute terms, about 10 in 100 people using nicotine e-cigarettes may quit smoking for at least six months, compared with about 6 in 100 using NRT. The review found no clear difference in serious adverse event rates between the two groups, while longer-term safety and the relative effectiveness of newer device types remain less certain.
Sep.07
Latest UK ONS Data: 54% of Vapers Are Former Cigarette Smokers, 26% Also Smoke and 20% Never Smoked Regularly
Latest UK ONS Data: 54% of Vapers Are Former Cigarette Smokers, 26% Also Smoke and 20% Never Smoked Regularly
Former cigarette smokers accounted for an estimated 54% of current e-cigarette users in Great Britain in 2025, while 26% also smoked cigarettes and 20% had never regularly smoked, according to a 2Firsts analysis of Office for National Statistics (ONS) data. Among former cigarette smokers who currently vape, approximately 81% used e-cigarettes daily, compared with about 50% of dual users. The ONS found that 33.8% of current cigarette smokers also vaped in 2025, up from 10.6% in 2014. Approximately 1.1 million adults who had never regularly smoked cigarettes used e-cigarettes, representing 2.9% of that population, compared with 0.2% in 2014. The figures highlight differences in the composition, frequency of use and long-term trends across Britain's vaping population.
DATA
Oct.14